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1. Introduction 
Orthopedic surgery is one of most blood-consuming surgical specialties since it is associated 
with a significant preoperative hemorrhage requiring frequent allogeneic blood 
transfusions. A special mention needs to be done to hip and knee arthroplasty, complex 
rachis arthrodesis and tumor-pathology removal. The intervention on older and higher-risk 
patients has raised the demand on allogeneic blood to such levels that even Blood Banks are 
unable to attend. Besides the high cost, using allogeneic blood has its risks, such as 
immunosuppression, patient’s wrong identification, transfusion reactions or the possibility 
of infectious disease transmission. This imbalance between blood demand and availability, 
together with the awareness about potential risks of blood transfusions and the continuous 
advances both in technology and pharmaceutics, should lead us to extreme changes in 
transfusion politics; developing a series of therapeutic measures to reduce blood transfusion 
to minimum, leaving its use only when it is strictly necessary, especially in scheduled 
surgery. 
 
PREOPERATIVE STRATEGIES
- Correction of preoperative anemia: iron supplements, erythropoietin, vitamin B12 
and folic acid 
- Autologous blood pre-donation
INTRAOPERATIVE STRATEGIES
- Individualize transfusion threshold 
- Anesthetic measures 
- Surgical technique 
- Erythrocytes’ substitutes 
- Pharmaceutical measurements 
- Autotransfusion: 
 Intraoperative blood savers 
 Normovolemic hemodilution 
POSTOPERATIVE STRATEGIES
- Autotransfusion of blood from postsurgical drainage 
- Iron supplements
Table 1. Blood-saving techniques during perioperative time. 
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The aim of this chapter is to inform on saving techniques of hematic components and its 
implantation in scheduled orthopedic surgery, summarized in table 1. 
2. Preoperative strategies 
2.1 Correction of preoperative anemia 
In the preanesthetic evaluation we will provide a guideline for preoperative evaluation and 
preparation of the patient, and we will include him/she to a blood-saving program by 
stimulating their erythropoietin (EPO) production, giving iron (Fe) or autologous blood 
predonation. It is important to check on hemoglobin levels, as well as iron deposits (ferritin, 
soluble transferrin receptor and transferrin saturation) and associated pathologies 
(comorbidity). 
Hemoglobin concentration is one of the most predictive factors for autologous blood 
transfusion (ABT). Patients with preoperative anemia show an increase in postoperative 
morbimortality and a decrease in quality of life (Shander et al., 2004). Age is a predisposing 
factor for anemia and the prevalence of postoperative anemia increases with age (Goodnough 
et al., 2005; Rosencher et al., 2003). Iron deficiency and chronic inflammation, with or without 
iron deficiency, are the most frequent causes of preoperative anemia in these patients. Folic 
acid and vitamin B12 deficiency can also be present, especially in elderly people.  
A preoperative anemia must be treated before undergoing surgery, if it is possible, limiting 
exposure risk to allogeneic blood. 
 Human recombinant erythropoietin (rhEPO) – For the past several years, we have at 
our disposal the human recombinant erythropoietin (rhEPO), obtained from genetic 
engineering, identical to the endogenous, which stimulates erythrocyte production in a 
dose-dependent way. It was considered that its use in surgical patients would arise 
preoperative hemoglobin values and/or facilitate autologous blood predonation, and 
this way decreasing the chances of an allogeneic transfusion. It is used in programmed 
patients undergoing major orthopedic surgeries in which initial hemoglobin is between 
10 and 13 g/dl, and the prediction of perioperative blood loss is significant (Laupacis & 
Fergusson, 1998).  
Its main function is stimulating the bone marrow’s erythropoietic activity, acting on 
specific receptors of erythrocyte-formation precursor target cells. Plasma levels of EPO 
do not vary with age or sex. In healthy individuals the rank goes from 5 – 25 mU/ml. 
EPO’s dosage varies according to its indication and it must be supplemented with iron 
to avoid stimulating an iron-deficient erythropoiesis. After undergoing a preoperative 
treatment with EPO, ferritin concentration decreases to half. The speed at which iron 
from this deposits can be activated becomes a limiting factor. Patients with serious 
cardiovascular disease, poorly controlled hypertension and history of thromboembolic 
disease or deep vein thrombosis cannot be treated with EPO. 
 Iron, vitamin B12 and folic acid – So that erythropoiesis works properly, besides EPO, 
it is necessary an appropriate iron intake (fundamental component in the hemoglobin 
molecule), as well as vitamin B12 and folic acid. Its deficiency affects the proliferation 
and cellular differentiation in erythropoiesis resulting in central arregenerative anemia 
(decreased reticulocytes). Total amount of iron in our organism is approximately 4-5 
grams. 65% is found as hemoglobin, whereas 15-30% is stored in the hepatic 
parenchyma and rethiculoendotelial system as ferritin and the rest of it binds to 
transferrin in blood plasma. It is absorbed in the small intestine. 
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Iron-deficiency anemia affects approximately 25% of world population. Furthermore, there 
is a status defined as ‘functional iron-deficient states’, which is described as a situation 
where iron deposits are normal (or even increased), but iron supply to bone marrow is 
inadequate to satisfy the erythroid precursor demands; and another anemia associated to 
‘chronic processes’ where erythropoiesis is deficient because of proinflammatory cytokines-
mediated mechanisms. 
Nowadays it has been proven its high profitability and efficiency index, mainly to optimize 
or as support in the erythropoietin treatment and autologous predonation. Administration 
of oral iron is effective in decreasing allogeneic blood transfusions and/or the number of 
transfused patients in orthopedic major surgery (Okuyama et al., 2005). Orally or 
intravenous use of iron will depend at the moment in which the treatment is taking place, 
oral iron absorptive capacity and existence of any gastric disease that could contraindicate 
oral iron treatment (Cuenca et al., 2004). If treatment is done with intravenous iron, once it is 
finished we must prescribe oral iron. 
The total amount of administered iron will depend on initial hemoglobin value and 
existence of an iron-deficient condition. If using saccharose iron, dosage varies from 100 to 
200 mg in alternate days, with a maximum dose of 600 mg per week and 200 mg every 2 
days. At present there is also carboxymaltose iron, which contains greater amounts of iron 
(500-1000 mg) to administer in a single dose. In case of a folic acid and/or vitamin B12 
deficiency we must supply substitutive treatment to correct it.  
2.2 Autologous blood predonation 
This means the presurgical patient’s blood predonation or autodonation. Some weeks prior 
to intervention, a blood extraction  (one or more units of blood) is performed to the patient 
to be used at his/her surgery or postoperatively.  
To be included in the program the patient must fulfill both medical and analytical special 
requirements; hemoglobin levels before starting predonation process above 11 mg/dl, as 
well as an appropriate programming of surgery to avoid expiration of the predonated units 
(35 days - maximum time permitted for storage). Due to this fact, quite a reasonable amount 
of patients who have undergone autologous blood donation preoperatively, reach surgery 
time with hemoglobin values under their initial levels (before predonation), therefore 
increasing transfusion requirements. The patient carries out the donations once or more 
times during the days and weeks prior to intervention. 350-400 mL extractions are made not 
less than 3-day intervals, which is the time needed for protein synthesis and mobilization 
and to return to normal. This way, they can benefit from erythropoiesis stimulation with 
erythropoietin. All patients must receive an appropriate iron supplement. 
Despite the fact that this technique was at its peak during the nineties, its use has been 
diminishing progressively for several reasons. In first place, the high number of blood bags 
that were dismissed because of an imbalance between extracted bags and transfusion 
requirements, since a good coordination in surgery programming and between all 
professionals taking part is needed. This difficulty has made this method a very expensive 
one in resource-consumption and less effective than it was thought to be at first. On the 
other hand, the establishment of intravenous iron and erythropoietin, decrease in 
transfusion threshold and improvement of the surgical method too, have pushed into the 
background autologous donation preoperatively, leaving it as last option in some cases such 
as complex spinal surgery with a mass blood loss forecast and those patients whose blood 
group have compatibility difficulties.  
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The existence of predonation units increases the likelihood of transfusion, as perception of 
risk decrease; there is less chance of rejection or blood incompatibility, as well as less 
infections. Moreover, it is exposed to the same errors in the processes of extraction, storage, 
identification and reinfusion to the autologous blood transfusion. Predonation of autologous 
blood has the following contraindications: serious cardiac disease, hepatitis B history and 
positive markers for HCV, HIV-I/II, HTLV-I/II and active bacterial infection. 
3. Intraoperative strategies 
To improve its efficiency, they must be associated to a blood-saving protocol during 
perioperative time. 
3.1 Individualize transfusion threshold 
A restrictive transfusion strategy (transfusion threshold at hemoglobin 7 g/dl) must be 
used, taking into consideration anemia risks and the benefits from a transfusion in an 
individualized way for every patient. Nowadays, rarely does hemoglobin over 10 g/dl get 
considered for transfusion, whereas it is believed to be strictly necessary when hemoglobin 
is less than 6 g/dl. In either case, the transfusion threshold must be lowered to try and delay 
the start of blood transfusion until the surgery ends, making a new assessment after each 
transfused packed red blood cells. Moreover, the usual practice of transfusing always two 
units of packed red blood cells (PRBC) is considered incorrect; as to raise the hemoglobin 
concentration 1 g/dl it takes about 4 ml/kg PRBC, being enough one PRBC. 
3.2 Anesthetic measures 
These include appropriate blood volume maintenance, dealing with pain, tachycardia and 
high blood pressure, hyperoxic ventilation to improve oxygen transport in patients with low 
hemoglobin and maintenance of normothermia. As specific actions in orthopedics we 
include: 
 Regional anesthesia, as several studies have demonstrated decrease of perioperative 
bleeding when comparing with general anesthesia, which appears to be related to lower 
blood pressure. 
 Optimal position of the patient to reduce venous congestion at the surgical field 
 Monitoring low blood pressure is a controversial anesthetic measure, with a relative 
effectiveness amongst bleeding, used to lower down blood pressure and thus reducing 
blood loss during surgery. In orthopedic surgery, its use gets relegated to high 
intraoperative bleeding interventions. Relative contraindications include untreated 
severe high blood pressure, coronary disease, serious lung disease, severe anemia or 
significant polycythemia, cerebrovascular disease, pregnancy, considerable 
hypovolemia and serious kidney or liver dysfunction. There are numerous drugs used 
to control hypertension. Most frequently used in clinical practice are inhalators 
(isoflurane, sevoflurane), direct acting vasodilators (nitroglycerin, sodium 
nitroprusside), beta blockers (labetalol, esmolol), others (urapidil, captopril, etc.) 
3.3 Surgical technique 
This includes an adequate ischemia (use of tourniquet), adequate hemostasis, minimally 
invasive surgery, etc. The most important factors are surgical time reduction and well-cared 
www.intechopen.com
 
Blood Transfusion in Knee Arthroplasty 
 
113 
hemostasis. There is a straightforward relationship between hematic loss and surgical time; 
a longer surgical time is associated to a greater hematic loss. During surgery, local 
hemostatic agents, such as fibrin sealants, which reduce surgical bleeding, can be used. We 
will develop this part further on. 
3.4 Erythrocytes’ substitutes 
These are substances able to replace the use of allogeneic blood components. They are 
obtained from human blood, transgenic animals or recombinant technology. Currently still 
under development. There are hemoglobin solutions and perfluorocarbonate emulsion. 
3.5 Pharmaceutical measurements 
Several prohemostatic drugs have been used in order to try reducing or preventing 
intraoperative bleeding. In orthopedic surgery, antifibrinolytic and desmopressin are the 
mainly used.  
3.5.1 Antifibrinolytics  
Perioperative bleeding is partially attributed to the fibrinolytic system activation. Several 
work groups have administered antifibrinolytics, and as a result observed a decrease in 
perioperative bleeding and blood bags transfused (Henry et al., 2001). In other recent 
revisions, which evaluate antifibrinolytics drugs in orthopedic surgery ( Kagoma et al., 2009; 
Zufferey et al., 2006), they conclude that using tranexamic acid or aprotinin reduces the 
percentage of patients requiring blood transfusions and also are efficient decreasing 
bleeding.  When using epsilon-aminocaproic acid (EACA) there are no signs of a significant 
reduction in hemorrhagic risk, although not many studies have been done. All of them can 
have relatively infrequent but very serious side effects, such as arterial thrombosis, renal 
failure or rhabdomyolysis. 
3.5.1.1 Aprotinin  
It is a 58 amino acid polypeptide. It is found mainly in mammalian mastocytes and it is 
commercialized from bovine lung. Aprotinin works inhibiting trypsin, plasmin and tissue 
and plasma kallikrein. In addition to this, it holds an anti-inflammatory effect attenuating 
inflammatory response in major surgery, particularly at high-doses. It is the antifibrinolytic 
drug most widely studied to reduce bleeding and diminish transfusion needs. However, in 
comparison to tranexamic acid or EACA, it increases mortality risk. After the adverse results 
in mortality in patients who had undergone cardiac surgery in an observational study over 
more than 4000 patients (Mangano et al., 2006), and in a randomized double blind trial with 
over 3000 patients (Fergusson et al., 2008), the drug was withdrawn worldwide. 
3.5.1.2 Synthetic antifibrinolytics 
Synthetic analogs of lysine. Tranexamic acid and EACA are able to block fibrinolysis by 
competitively antagonizing the binding of plasminogen to fibrin. 
Tranexamic acid is 10 times stronger in vitro than EACA. In total knee arthroplasty, 
prophylactic administration significantly reduces blood loss up to 50% and decreases 
transfusion requirements without increasing the risk of thromboembolic signs (Alvarez et 
al., 2008; Cid & Lozano, 2005; Lozano et al., 2008). Optimal technique would be with two 
tranexamic acid bolus (each of them 10-15 mg/Kg), one before surgery and another when 
letting the air out of the tourniquet. In total hip prosthesis, tranexamic acid results in a 
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decrease of intraoperative bleeding when administered prophylactically (Benoni et al., 
2001), with no raise in thromboembolic complications incidence (Johansson et al., 2005b). 
However, it must only be used in those patients of whom a significant blood loss is 
expected. In spinal surgery, its administration is associated with considerable decrease in 
perioperative blood loss without side effects coming out (Elwatidy et al., 1976).  
The rapid administration causes hypotension and its use is not recommended in patients 
with thromboembolic history although there is no evidence of an association with 
thromboembolic complications arising.   
Epsilon-aminocaproic acid (EACA), in addition to its antifibrinolytic effect, prevents from 
platelet receptor degradation by plasmin, preserving platelet function. On the whole, 
recommended dose is a 150-mg/Kg bolus before surgery, followed by a 15-mg/Kg/h 
infusion during surgery. In a 2008-published meta-analysis they concluded that it is the 
most effective antifibrinolytic drug in spinal surgery (Gill et al., 2008). Nevertheless, not 
many studies have been done regarding this drug as to obtain conclusions. The most 
frequent side effect is hypotension, which is usually associated to a rapid intravenous 
administration. There is no evidence that EACA would raise thromboembolic episodes. 
3.5.2 Desmopressin acetate 
Desmopressin acetate is an antidiuretic hormone synthetic analogue. Besides its antidiuretic 
effect, it has a hemostatic action that would be based in factor VIII and Von Willebrand 
factor release to the circulatory system from the existent deposits at the vascular 
endothelium cells, and its ability for increasing platelet adhesion. In orthopedic surgery its 
use has been reduced mainly to spinal surgery, with initial encouraging results (Kobrinsky 
et al., 1987), although not proved in subsequent studies. In hip and knee orthopedic surgery 
there is no evidence of a decrease in blood loss or erythrocyte volume transfusion. Dose for 
intravenous administration is 0.3 g/Kg and its main use would be for Von Willebrand 
syndrome. Desmopressin side effects include facial redness, severe headache, hypotension 
and high-speed beating. Its strong antidiuretic effect can produce water retention, 
hyponatremia and convulsions. 
3.6 Autotransfusion 
It includes all the procedures by which a patient is transfused with his own blood. These 
methods have a number of advantages such as lack of infectious diseases transmission, 
avoids hemolytic disease incidence and several different transfusion reactions, it has 
immediate availability, as well as compatibility, avoids categorization and cross-matching 
mistakes, and last of all, decreases hypothermal risk of stored blood. It can be performed by 
two different methods: 
3.6.1 Normovolemic hemodilution 
Normovolemic hemodilution consists in extraction and anticoagulation of an established 
blood volume (4 units maximum) after anesthetic induction and its simultaneous 
substitution for crystalloids and/or colloids to maintain normovolemia, and thus causing 
dilutional anemia. Reinfusion is done later on when surgical hemorrhage is under control or 
even before if necessary. Extracted blood is then anticoagulated at room temperature, which 
preserves platelet functions. Despite these theoretical benefits, dissolving coagulation 
factors, hematocrit and platelets causes a microvascular bleeding. Furthermore, excessive 
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crystalloid contribution leads to their accumulation on the interstitial space during 
postoperative time and it is currently considered as an obsolete technique, mostly because of 
its inefficiency as a blood-saver method. Nowadays the use of normovolemic hemodilution 
is not recommended for decreasing allogeneic blood transfusion, nor transfused patient 
number or bags transfused.  
3.6.2 Intraoperative blood savers 
Retrieving intraoperative blood involves autologous collection and infusion of autologous 
red blood cells, which is done by means of a device known as cell saver. It is commonly 
used in orthopedic surgery (spinal surgery and replacement of hip prosthesis) and provides 
significant autologous blood volumes. In major orthopedic surgery, perioperative blood 
retrieval reduces the probability of receiving autologous blood transfusion by 65% (Carless 
et al., 2004). The devices used recover only 50-60% of lost blood during surgery, which 
together with the high cost of consumables, makes its use only indicated to those procedures 
in which intraoperative hemorrhage is predicted to be over 1,000-1,500 ml, or else when it is 
possible to recover at least one packed red blood cells. This method would also be indicated 
in those patients whose religious believes contraindicates a blood donor transfusion but 
permits an autologous transfusion, when no compatible blood donor is available or when 
the patient is not capable of donating enough amount of autologous blood before surgery.  
Despite the devices’ costs, retrieved and processed blood can be less expensive than 
allogeneic blood (Gardner et al., 2000). A clear benefit from perioperative blood reinfusion is 
the erythrocyte viability in collected blood, which is higher than that from allogeneic blood 
and oxygen transport capacity, being better than in stored blood (Colwell, Jr. et al., 2002). 
However, autotransfusion programs are associated with certain organization complexity 
and a weak cost-benefit relationship when used indiscriminately. 
This procedure is contraindicated when there is bacterial contamination at the operating field, 
neoplastic disease, patients with positive viral-markers, sickle-cell anemia and when certain 
local hemostatics have been used or else when blood is found to be hemolyzed. Different 
procedures are available for intraoperative blood recovery. Semicontinuous-flow blood 
centrifugation system is one of the most commonly used, where blood is retrieved by 
aspiration, anticoagulated, filtered and sent to a reservoir from where it is pumped to a 
centrifuge bell which divides and washes the cells to return them to the patient as a saline 
suspended red blood cells, with a hematocrit value around 50-70%. During this process, plasma 
is dismissed, as well as toxic products from hemolysis, coagulation factors, platelets and fat. 
OrthoPAT® (Orthopedic Perioperative Autotransfusion System, Haemonetics), is an 
autologous blood retrieval, specifically designed for adapting to intermittent bleeding 
during and after programmed orthopedic surgery, reducing unnecessary allogeneic 
transfusions. It is a small device, easy to operate and completely automatized. In prosthetic-
hip and spinal surgery it is commonly used for intra and postoperative retrieval, whereas in 
prosthetic-knee surgery it is preferably used postoperatively. Perioperative use of blood 
retrievals may significantly reduce allogeneic transfusion risks in a not inconsiderable 
number of patients with high-risk of being transfused (Pola et al., 2004). 
4. Postoperative strategies 
4.1 Postoperative autotransfusion 
There are certain orthopedic surgical procedures (such as knee arthroplasty), in which 
postoperative bleeding through postsurgical drainages is very significant due to the 
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completion of most of the surgery with lower extremity ischemia, so that bleeding occurs 
primarily in the early hours of the postoperative period. For this reason, in this type of 
surgeries, blood retrieval during postoperative time has been the main instruction and the 
one that has achieved major performance. Several devices for postoperative blood retrieval 
have been designed, in order to aspirate, store and retransfuse lost blood through 
postsurgical drainages. 
Reinfused blood is often filtered rather than washed. It would be restricted to orthopedic 
programmed surgeries where estimated postoperative bleeding is between 750 and 1000 
mL, and at least the equivalent to one packed red blood cells can be retrieved. 
Autotransfused blood must be collected and reinfused within a 4-6 hour-period. Stored 
blood in surgical drainage holds a better oxygen release to tissues than that from blood 
bank, although having a lower hematocrit. Furthermore, it owns better rheological 
characteristics and fewer ionic disturbances than blood bank. Hematocrit is low because it is 
total blood, which means that with this blood reinfusion we will not be able to raise 
hematocrit, but we will succeed in not diminishing its value. 
Comparison analysis from obtained data in several studies shows that, regarding blood 
bank, blood from postsurgical drainage in orthopedic surgery, even with lower 
hematocrit and hemoglobin (8-10 g/dL), has higher concentrations of erythrocytic ATP 
and 2,3-BPG, less ionic disturbances and possibly, less immunosuppressive action. This 
blood includes too activated coagulation factors and fibrinogen degradation products, 
which could be the cause of coagulopathies. However, no significant increase in bleeding 
has been found, neither coagulation disorders clinically expressive There are no 
differences in perioperative inflammatory mediators levels between patients receiving 
unwashed retrieved blood from those who do not get it (Munoz et al., 2005b). Fat particles 
content, which is the main cause of fat embolism and respiratory distress syndrome, is 
controlled using a filter between collection and reinfusion container, and dismissing the 
last 80-100 cc. These methods allow removal of 90% of fat particles in the retrieved blood. 
The remaining 10% is eliminated by leukodepletion filter. These filters have shown to be 
effective in dismissing bacteria and tumor cells. In accordance with the abovementioned, 
unwashed blood must be limited to a maximum 1000 ml reinfusion. This collecting system 
brings advantages such as minimum contamination risk as it is a closed circuit and 
greater hemodynamic stability during postoperative period due to the disposal of blood 
volume, which is reinfunded if necessary. Moreover, it is cheap and can be used in 
Jehovah’s Witnesses, as it is a closed circuit in which blood does not lose total contact 
with the patient’s body. 
Contraindications for using postsurgical drains’ blood are: renal failure, altered hepatic 
function, coagulation disorders, infusion of hemostatic agents or inadequate solutions (topic 
antibiotics, antiseptics, oxygenated water) and neoplastic or septic disease. Retrieval of 
postoperative blood reduces both patients’ percentage that would receive allogeneic blood 
transfusion and volume of transfusion (Carless et al., 2004). 
4.2 Iron supplements  
The use of intravenous iron during postoperative of orthopedic-surgical patients, is an 
effective treatment to increase hemoglobin levels, as shown in five clinical trials randomized 
controlled; unlike oral iron supply. 
www.intechopen.com
 
Blood Transfusion in Knee Arthroplasty 
 
117 
5. Surgical aspects and its relationship with bleeding 
5.1 Introduction 
Transfusion requirements are a matter that concerns doctors not only for disease 
transmission risk but also for transmission complications and the high-cost of the procedure 
(Garcia-Erce et al., 2002). There has been a recent trend towards developing a protocol in 
order to decrease transfusion requirements (Garcia-Erce et al., 2002; Kourtzis et al., 2004). 
Several options have come up, pharmaceutical as well as transfusion options alternatively to 
allogeneic transfusion, summed up in table 2. 
According to different studies who have studied predictive factors in trauma surgeries, 
preoperative hemoglobin level and levels of red cell mass are predictors of transfusion 
needs. The higher the levels of hemoglobin and red cell mass, the less need to transfuse 
(Garcia-Erce et al., 2002; Lozano et al., 2008). 
Occult blood has an outstanding paper regarding blood management in the patient being 
operated of arthroplastic surgery. Occult blood can reach 50% of the missed blood 
perioperatively (Sehat et al., 2000).  
During surgery there are several options to consider in order of preventing bleeding, such 
as: use or not have drainages, aspiration pressure and time of aspiration of drainages and 
the use of ischemia during prosthetic surgery. 
 
SURGICAL VARIABLES 
1. Drainages and non-infectious complications 
2. Relation between drainage and infection 
3. Use of postoperative blood retrieval 
4. Number of drainages 
5. Aspiration pressure 
6. Start / Opening-up / End of drainage 
7. Tourniquet 
8. Surgical technique 
Table 2. Different surgical options to reduce bleeding 
5.2 Drainages and non-infectious complications 
The use of drainages in orthopedic surgery is a matter of tradition. Its use prevents 
postoperative hematomas and diminishes postoperative pain, but its use is still 
controversial (Corpe et al., 2000). Despite several evidence-based medical studies, British 
orthopedists were not following their recommendations in 2003 (Canty et al., 2003).  
Drains have been related to the transfusion necessity and infection rate, among others. But 
some studies, such as Seyfert’s et al (Seyfert et al., 2002), prove that placing drainages with 
suction does not increase transfusion requirements or postoperative course. 
On the other hand, there are studies whose results highlight that not using drainages does 
not avoid transfusions nor does it reduce blood loss. Padala et al. find questionable the use 
of drainages in primary knee surgery as it increases transfusions (Padala et al., 2004). Some 
studies hold on to the fact that it is not necessary their use in primary knee arthroplasty 
(Adalberth et al., 1998; Corpe et al., 2000; Jenny et al., 2001), nor hip or knee (Crevoisier et 
al., 1998; Niskanen et al., 2000), nor primary hip (Acus, III et al., 1992; Beer et al., 1991; 
Hadden & McFarlane, 1990; Kumar et al., 2006). Della Valle et al found out in their study 
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more complications in the group with drainages in comparison to the non-drainages group 
in primary hip arthroplasty (Gonzalez, V et al., 2004). Ovadia et al (Ovadia et al., 1997), as 
well as other work-groups (Hallstrom & Steele, 1992; Walmsley et al., 2005), find significant 
the premise that the use of drainages increases transfusion requirements (0.7 units per 
patient with drainage, in comparison to 0.2 unit per patient without, p = 0.005). 
Widman et al.(Widman et al., 2002) reveal in their study that the use of drainages in hip 
surgery does not decrease postsurgical hematoma, analyzed with SPECT, but it does 
increase transfusion requirements. 
Esler et al. (Esler et al., 2003) state that they cannot support the use of suction drainages as 
the group with suction drainages shows a greater blood loss than the non-drainages group. 
Nevertheless, they do give support to the use of drainages for reusing blood. 
Some authors assert that the use of drainage is not harmful but it is of no use at all (Ashraf et 
al., 2001; Johansson et al., 2005a). Other authors do not see that using drainages in 
unicompartmental knee surgery has an adequate cost/benefit ratio, since it increases the 
cost of the procedure both in labor and equipment expenditure; and furthermore, avoiding 
postoperative drainage in this kind of procedures does not influence the outcome 
(Confalonieri et al., 2004).  
In their meta-analysis, Parker et al. (Parker et al., 2004) find out that suction drainage 
increases transfusion requirements after a hip or knee arthroplasty, with no benefits 
contributed.  
A mechanical complication that may occur with Redon-drains is that this can break, thus 
staying intra-articular. In the knee’s joint we may keep an expectant management or else 
require surgical maneuvers such as arthrotomy (Marmor, 1990) or either arthroscopy 
surgery to remove the drainage (Kao et al., 2002). 
5.3 Relation between drainage and infection 
Once we reach the infectious complications, the debate remains open. On the one hand, the 
fact that drains decrease hematoma, knowing that hematoma is an enabling factor for 
infection, is an argument for its use. But on the other hand, drainages can increase 
retrograde infection (Mengal et al., 2001). 
Regarding deep infections, studies are controversial. Some authors, e.g. Kim et al., defend 
that using drainages does not increase infections rate or it even decreases it. These associate 
drains’ use with a non-significant decrease in deep infections (Kim et al., 1998). 
On the other hand, many authors present results where drains’ use has a positive relation to 
infection. Minnema et al. (Minnema et al., 2004)have linked the use of suction drains with an 
increasing rate of surgical wound infection after total knee arthroplasty. 
Cultivating the drain’s end is not a favorable practice in cost-benefit studies, according to 
the study published by Weinrauch et al. (Weinrauch, 2005). In spite of Weinrauch’s study, 
several groups have cultivated the drain’s tip. Zamora-Navas et al. (Zamora-Navas et al., 
1999) analyze the drain’s tip observing that drainages removed before 12 hours do not have 
any contamination, those retired at 24 hours show contamination in 2 out of 12 patients for 
Staphylococcus epidermidis, and those drains removed at 48 hours also present contamination 
for S. epidermidis in 2 out of 12 patients. Clinical evaluations of wound healing were similar 
in both groups. A different group of study, Willemen’s et al. (Willemen et al., 1991), 
cultivated the catheter’s tip of all groups and concluded that culture of the catheter’s end 
that had been removed at 24 hours time, were all-negative cultures. A related study to the 
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abovementioned is that from Schmitt et al. (Schmitt & Weyand, 1997), in which a greater 
number of hours maintaining the drainage increases bacterial contamination of the drainage 
tip. Therefore, Willemen (Willemen et al., 1991), Drinkwater et al. (Drinkwater & Neil, 1995) 
and Rowe’s et al. (Rowe et al., 1993) groups recommend use of drainages up to 24 hours, 
owing to the relationship between use of drains, microbial contamination in the catheter’s 
tip, risk of prosthetic infection and comfort in early rehabilitation. 
Regarding superficial infections, authors such as Saleh et al. (Saleh et al., 2002) and Ovadia 
et al. (Ovadia et al., 1997), find in their studies that superficial infection is significantly 
related to use and duration of drainages. 
5.4 Use of postoperative blood retrieval 
Within the options in saving blood we can use intraoperative and postoperative blood 
retrieval. Regarding the use of blood retrieval in total knee ( Dalen et al., 1996; Gannon et al., 
1991; Groh et al., 1990; Handel et al., 2006; Heddle et al., 1992; Hendrych, 2006; Kristensen et 
al., 1992; Majkowski et al., 1991; Martin et al., 1992; Munoz et al., 2005a; Noain et al., 2005; 
Simpson et al., 1994; Strumper et al., 2004; Thomas et al., 2001; Wojan et al., 2005; Xenakis et 
al., 1997) and hip (Gannon et al., 1991;Kristensen et al., 1992) arthroplasty, it is considered to 
be useful as it decreases blood transfusion necessity, reaching a 48% decrease transfusion 
requirements. 
The use of postoperative retrieval in knee or hip primary surgery, analyzed from a cost-
benefit point of view, is a profitable procedure ( Dramis & Plewes, 2006; Jones et al., 2004; 
Thomas et al., 2001; Wojan et al., 2005). However, some authors like Umlas et al. show that 
the use of a retrieving instrument is not profitable due to its high cost and the small amount 
of blood retrieved (Umlas et al., 1994). Slagis’ group (Slagis et al., 1991) find that using a 
retrieval is actually associated to a diminishment in costs, but it is not recommended as a 
systematic manner in all patients undergoing total knee arthroplasty as the amount of blood 
salvaged is low and they still need blood transfusions. 
The amount of blood salvaged in hip arthroplasty surgery is 350-700 mL and 500-800 mL in 
knee arthroplasty (Dutka et al., 2002), although other groups state that the average 
transfused amount is around 1000 mL in knee arthroplasty (Breakwell et al., 2000). The 
study by Han et al. (Han & Shin, 1997) shows that using a retrieval is useful as it is possible 
to reinfuse 437 mL in hip, 883 mL in knee arthroplasty and 1713 mL in bilateral knee surgery 
without patients having any air embolism problem, coagulopathy, renal failure or sepsis. 
The followed protocol in blood retrieval is the reinfusion of the collected blood within 6 first 
hours (Dalen et al., 1995). Using blood from postoperative drainage (blood retrieval) in knee 
arthroplasty does not show important complications (Groh et al., 1990; Sinardi et al., 2005; 
Wojan et al., 2005), neither inflammatory cell response increase ( Altinel et al., 2006; Munoz 
et al., 2005b; Munoz et al., 2006). According to different studies there are no statistically 
significant differences within the studied parameters, except for IL-6, which could increase 
febrile reactions ( Handel et al., 2006; Kristiansson et al., 1995). In the study by Bengtson et 
al. (Bengtson et al., 1990) they found a decrease of anaphylactic toxin and complement 
activation with no clinical impact. Woda et al. (Woda & Tetzlaff, 1992) describe a case with 
tracheal edema post-reinfusion of salvaged blood. 
The recovered blood culture may be positive in some cases, for this reason Wollinsky et al. 
recommend antibiotic prophylaxis with cefuroxime to reduce contamination of suction tips 
and collection bags (Wollinsky et al., 1997). This same study shows that the use of 
prophylactic cefuroxime limits the transfer of autologous blood products. 
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Several studies compare the different blood retrievals, finding out that whereas some are 
easier to use, others have a better suction and that side effects do not present statistically 
significant differences (Trammell et al., 1991). 
Another point of view to look at is that from Mauerhan et al. (Mauerhan et al., 1993) and 
other authors (Mac et al., 1993; Reize et al., 2006), who find that the use of a recovered blood 
is not necessary in hip and knee arthroplasty. Faraj et al. show in their study that cost/profit 
ratio is not profitable when using a blood retrieval (Evans et al., 1993; Faraj & Raghuvanshi, 
2006; Jackson et al., 2000). 
5.5 Number of drainages 
The study by Labek et al. (Labek & Bohler, 1998) links the number of drainages with 
prosthetic hip bleeding. Their article studies the relationship between number of drainages, 
its positioning (deep and/or superficial) and its relationship with transfusions needed, 
wound’s exudation, subcutaneous hematoma and thigh edema. Given the possibility of 
placing three drainages, two drainages, (subcutaneously and subfascial) or one drainage 
(subcutaneously or subfascial), the conclusion was that using two drainages alone is better 
rather than 3 drainages or no drainage as there are no more complications with respect to 
surgical injury and a 47% reduction of blood units was achieved. 
5.6 Aspiration pressure 
Aspiration pressure is one of many variables when using drains. Cheung et al. state that low 
suction drains do not increase the number of complications (Cheung & Chiu, 2006). Along 
the same lines, Benoni et al (Benoni & Fredin, 1997) show that a high aspiration pressure 
increases drained quantity after knee arthroplasty in a significant way with respect to low-
pressure aspiration drainages. The average drained amount in 24 hours is 570 mL in high-
pressure aspiration drains and 480 mL in low-pressure ones (p=0,03). At 48 hours, drained 
quantity had raised to 785 mL and 585 mL (p=0,002) respectively.  
Another study regarding aspiration pressure is that from Kirschner et al. (Kirschner et al., 
1989) where it is observed that the higher suction pressure increases the risk of secondary 
hematomas. Martin et al. (Martin et al., 2004), in their study with three groups (no 
drainages, suction drainages and a third group with non-suction drains), find that the group 
using non-suction drainages is that with fewer complications and less transfusion 
requirements. 
When studying another variable such as time of aspiration (continuous or discontinuous), 
and according to Berman et al. (Berman et al., 1990), using continuous aspiration increases 
drained amount, however it also decreases complications from the surgical wound and 
transudation through surgical injury. Another study evaluating results from a 
discontinuous opening of the drain is that from Brueggemann, who shows that clamping the 
drainages during 55 minutes every hour for the first 6 postoperative hours decreases 
transfusion needs, without increasing the risk of hematomas or complications from the 
surgical wound (Brueggemann et al., 1999). Prasad et al. in their study show that an 
intermittent clamping of drains decreases bleeding, rather than clamping the drainage only 
initially for 2 hours (Prasad et al., 2005).  
Seyfert et al. (Seyfert et al., 2002) compare a group with unicompartmental knee 
prosthesis with suction drainage and another one with no drainage. The study analyzes 
bleeding at 12, 24, 36 and 48 hours. Average bleeding in the suction-drainage group was 
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528 mL, whereas in the non-suction 436 mL. However, difference between both averages 
was not statistically significant. 
5.7 Start/opening-up/end of drainage 
If the opening-up of drainage is delayed, the obtained amount through drainage diminishes 
in a statistically significant manner (Roy et al., 2006; Tsumara et al., 2006). Along the same 
lines, another study states that delaying the opening-up of drainages 4 hours; drainage 
decreases in a statistically significant way (Shen et al., 2005). 
On the other hand, some authors conclude that clamping drains during first 2 
postoperative hours does not influence within drained quantity, nor transfusion number, 
or mobility, or surgical wound complications (Kiely et al., 2001). Study by Leemann et al. 
affirms that after 6 hours drainage can be removed as 78% of bleeding has been already 
drained (Leeman et al., 2006). 
Senthil et al. (Senthil et al., 2005) state in their study that 84% of total drain was collected 
during first 12 hours, and 94% during first 24 hours. The study’s conclusion is that articular 
drainages can be safely removed after first 12 postoperative hours. 
The Spanish group headed by Zamora-Navas (Zamora-Navas et al., 1999) study bleeding 
features in three groups in which drainage is maintained 12, 24 and 48 hours. They observed 
that the group maintaining drainage for 24 hours had already drained 87% of the total 
amount at 12 hours time. In the last group (with drainage 48 hours), bleeding at 12 hours 
corresponded to 91% of the total amount, and bleeding at 24 hours was 97% of the total 
amount collected after 48 hours. 
Regarding when to remove drainage, in the study by Benoni et al. (Benoni & Fredin, 1997) 
we can observe how the drained amount between 24 and 48 hours is only 215 mL in the 
high-pressure aspiration drainages, and 105 mL in those with low-pressure aspiration. In 
conclusion, we can see that aspiration pressure is not more than a variable, as previously 
seen, and that drained volume between 24 and 48 hours is not as far as important as the 
bleeding that occurs during first 24 hours. 
In the study by Slagis et al., the conclusion of greater volume collected during first operative 
hours repeats (Slagis et al., 1991). The average collected volume was 493 mL, great part of it 
being collected during first 4 hours. 
Another study showing that prosthetic bleeding is produced during first postsurgical hours 
is that from Willemen et al. (Willemen et al., 1991), in which they keep drains 48 hours and 
they observe that 85% of total volume was drained after 24 hours. Between 24 and 48 hours 
the drain was of only 50 mL. 
In our own study (Ares-Rodriguez et al., 2008), we observed that mean of the survival curve 
for postoperative bleeding time was 16 hours for total knee arthroplasty, and we therefore 
concluded that drainage in total knee arthroplasty can be safely removed after 18 
postoperative hours, with a safety margin. 
5.8 Tourniquet 
A first study shows that releasing the tourniquet intraoperative (before wound closure) and 
a correct hemostasis does not reduce total amount of blood lost in total knee arthroplasty 
(Hersekli et al., 2004). Barwell et al. (Barwell et al., 1997) present in their study that using 
tourniquet has some side effects and that these can be minimized if removal of tourniquet is 
done prematurely, together with a thoroughly hemostasis prior to surgical wound closing. 
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Lotke finds in his study that releasing tourniquet, together with coagulation and 
immediate start of continuous passive motion (CPM) therapy, increases arthroplasty 
bleeding (Lotke et al., 1991). 
5.9 Surgical technique 
Regarding which surgical technique would most reduce postoperative bleeding, several 
maneuvers have been discussed; such as navigation, sealing the intramedullary femoral 
canal during femoral preparation in total knee arthroplasty, different prosthetic models and 
using minimally invasive techniques. 
The use of the navigator reduces bleeding through drainage in a statistically significant way, 
according to the studies by Kalairajah (Kalairajah et al., 2005) and Hinarejos (Hinarejos et al., 
2009). On the other hand, groups such as Chang’s (Chang CW et al., 2010) or Turajane’s 
(Turajane T et al., 2009) do not find statistically significant differences between minimally 
invasive surgery with navigation and conventional surgery. 
Sealing the intramedullary femoral canal in non-navigated surgery and with intramedullary 
femoral guide decreases both the fall in hemoglobin and transfusion requirements in a 
statistically significant way ( Ko et al., 2003; Raut et al., 1993). Another study showed a 
decrease in bleeding through drainages with this technique (Kumar et al., 2000). 
Porteous et al. (Garcia-Erce et al., 2002; Porteous and Bartlett, 2003) analyze postoperative 
drainage in three implant types; cemented, hybrid and uncemented total knee replacement. 
The statistically significant conclusion is that cemented prosthesis has a lesser bleeding with 
regard to other two groups during 8 first hours, but this difference decreases after 24-48 hours. 
Another study states that constrained arthroplasty increases blood loss (Berman et al., 1988). 
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